Optimization of Culture Conditions for HBV-specific T Cell Expansion in Vitro from Chronically Infected Patients

Overview

Journal BMC Biotechnol

Publisher Biomed Central

Specialty Biotechnology

Date 2024 Oct 14

PMID 39402512

Authors

Li Wang

Hongjiao Chen

Yuanqi Yang

Ying Huang

Weixian Chen

Di Mu

Affiliations

Soon will be listed here.

Abstract

Background: Hepatitis B virus (HBV) clearance depends on an effective adaptive immune response, especially HBV-specific T cell-mediated cellular immunity; however, it is difficult to produce enough HBV-specific T cells effectively.

Results: In this work, we investigated the proportions of stimulated cells, serum, and culture media as the three primary factors to determine the most effective procedure and applied it to HLA-A2 (+) people. In parallel, we also examined the correlation between clinical parameters and HBV-specific immunity. Concerning amplification efficiency, 4 × 10 cells stimulation was superior to 2 × 10 cells stimulation, AIM-V medium outperformed 1640 medium, and fetal bovine serum (FBS) exceeded human AB serum under comparable conditions. As expected, this procedure is also suitable for developing HBV-specific CD8 + T cells in HLA-A2(+) individuals. Expanded HBV-specific T cell responses decreased with treatment time and were negatively correlated with HBV DNA and HBsAg. Furthermore, the number of HBV-specific IFN-γ + SFCs was strongly correlated with the ALT level and negatively correlated with the absolute lymphocyte count and the ALB concentration.

Conclusions: We confirm that stimulating 4 × 10 PBMCs in AIM-V medium supplemented with 10% FBS is the best approach and that HBeAg, HBsAg, and ALB are independent predictors of HBV-specific T-cell responses.

References

Canestrari E, Steidinger H, McSwain B, Charlebois S, Dann C . Human Platelet Lysate Media Supplement Supports Lentiviral Transduction and Expansion of Human T Lymphocytes While Maintaining Memory Phenotype. J Immunol Res. 2019; 2019:3616120. PMC: 6746159. DOI: 10.1155/2019/3616120. View

Fu Y, Zhou S, Hu W, Li J, Zhou M, Li X . Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B. Hepatol Int. 2023; 17(5):1125-1138. PMC: 10522531. DOI: 10.1007/s12072-023-10490-4. View

Schuch A, Salimi Alizei E, Heim K, Wieland D, Kiraithe M, Kemming J . Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load. Gut. 2019; 68(5):905-915. DOI: 10.1136/gutjnl-2018-316641. View

Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T . Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 2007; 81(8):4215-25. PMC: 1866111. DOI: 10.1128/JVI.02844-06. View

Lu T, Pugach O, Somerville R, Rosenberg S, Kochenderfer J, Better M . A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies. Hum Gene Ther Methods. 2016; 27(6):209-218. PMC: 6445175. DOI: 10.1089/hgtb.2016.120. View

Guidotti L, Ando K, Hobbs M, Ishikawa T, Runkel L, Schreiber R . Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A. 1994; 91(9):3764-8. PMC: 43662. DOI: 10.1073/pnas.91.9.3764. View

Chun E, Lee J, Cheong H, Lee K . Tumor eradication by hepatitis B virus X antigen-specific CD8+ T cells in xenografted nude mice. J Immunol. 2003; 170(3):1183-90. DOI: 10.4049/jimmunol.170.3.1183. View

Chen C, Jiang X, Liu X, Guo L, Wang W, Gu S . Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay. J Leukoc Biol. 2020; 109(2):455-465. DOI: 10.1002/JLB.5MA0620-023RR. View

Chen J, Wang Y, Wu X, Li J, Hou F, Wang G . Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B. World J Gastroenterol. 2010; 16(48):6145-50. PMC: 3012572. DOI: 10.3748/wjg.v16.i48.6145. View

10.

Van Stipdonk M, Lemmens E, Schoenberger S . Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol. 2001; 2(5):423-9. DOI: 10.1038/87730. View

11.

Salimzadeh L, Bert N, Dutertre C, Gill U, Newell E, Frey C . PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection. J Clin Invest. 2018; 128(10):4573-4587. PMC: 6159957. DOI: 10.1172/JCI121957. View

12.

Wen C, Zhou Y, Zhou Y, Wang Y, Dong Z, Gu S . HBV Core-specific CD4 T cells correlate with sustained viral control upon off-treatment in HBeAg-positive chronic hepatitis B patients. Antiviral Res. 2023; 213:105585. DOI: 10.1016/j.antiviral.2023.105585. View

13.

Lopes A, Kellam P, Das A, Dunn C, Kwan A, Turner J . Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest. 2008; 118(5):1835-45. PMC: 2289792. DOI: 10.1172/JCI33402. View

14.

Gehring A, Koh S, Chia A, Paramasivam K, Chew V, Ho Z . Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection. PLoS One. 2011; 6(8):e23330. PMC: 3158071. DOI: 10.1371/journal.pone.0023330. View

15.

Tan A, Loggi E, Boni C, Chia A, Gehring A, Sastry K . Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol. 2008; 82(22):10986-97. PMC: 2573267. DOI: 10.1128/JVI.01124-08. View

16.

Loggi E, Bihl F, Cursaro C, Granieri C, Galli S, Brodosi L . Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. PLoS One. 2013; 8(6):e65327. PMC: 3672146. DOI: 10.1371/journal.pone.0065327. View

17.

Urbani S, Boni C, Missale G, Elia G, Cavallo C, Massari M . Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol. 2002; 76(24):12423-34. PMC: 136708. DOI: 10.1128/jvi.76.24.12423-12434.2002. View

18.

Shimada N, Yamamoto K, Kuroda M, Terada R, Hakoda T, Shimomura H . HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells. J Clin Immunol. 2003; 23(3):223-32. DOI: 10.1023/a:1023366013858. View

19.

Zheng J, Wang Z, Feng B . Hepatitis B functional cure and immune response. Front Immunol. 2022; 13:1075916. PMC: 9714500. DOI: 10.3389/fimmu.2022.1075916. View

20.

Sato K, Kondo M, Sakuta K, Hosoi A, Noji S, Sugiura M . Impact of culture medium on the expansion of T cells for immunotherapy. Cytotherapy. 2009; 11(7):936-46. DOI: 10.3109/14653240903219114. View